ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is a multi-center double-blind parallel-group study in involutional osteoporosis
patients to compare the efficacy and safety of monthly oral intermittent formulation
ONO-5920/YM529 with its daily formulation.